Levetiracetam induced psoriasiform drug eruption: a rare case report

dc.authoridAltunel, Cemile Tugba/0000-0002-2609-8208;
dc.contributor.authorGencler, Onur Serdar
dc.contributor.authorGencler, Bilgen
dc.contributor.authorAltunel, Cemile Tugba
dc.contributor.authorArslan, Nur
dc.date.accessioned2025-10-24T18:09:05Z
dc.date.available2025-10-24T18:09:05Z
dc.date.issued2015
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractLevetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam. To our knowledge this is the first report of a patient with a psoriasiform eruption that appeared after the administration of LEV. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
dc.identifier.doi10.1016/j.jsps.2015.02.010
dc.identifier.endpage722
dc.identifier.issn1319-0164
dc.identifier.issn2213-7475
dc.identifier.issue6
dc.identifier.pmid26702269
dc.identifier.scopus2-s2.0-84952871765
dc.identifier.scopusqualityQ2
dc.identifier.startpage720
dc.identifier.urihttps://doi.org/10.1016/j.jsps.2015.02.010
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3461
dc.identifier.volume23
dc.identifier.wosWOS:000365833800017
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Bv
dc.relation.ispartofSaudi Pharmaceutical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20251023
dc.subjectLevetiracetam; Epilepsy; Psoriasiform drug eruption
dc.titleLevetiracetam induced psoriasiform drug eruption: a rare case report
dc.typeArticle

Dosyalar